Press release
Global Pernicious Anemia Market Research and Forecast, 2018-2023
Pernicious Anemia Market
According to OMR analysis, the global pernicious anemia market is estimated to grow at a significant CAGR during the forecast period (2018-2023). The elderly people are more prone to such disease. The increasing prevalence of autoimmune condition or intestinal diseases is the major motivating factor for the growth of the global pernicious anemia market. Moreover, effective medication techniques for treating autoimmune disorders also accounts for the growth of the market.
A full report of global pernicious anemia market is available at https://www.omrglobal.com/industry-reports/pernicious-anemia-market/
Furthermore, the global pernicious anemia market is segmented on the basis of diagnosis, treatment, and end-user. The report provides detailed & insightful chapters which include market overview, key findings, strategic recommendations, market estimations, market determinants, key company analysis, market insights, company profiling, market segmentation, geographical analysis, analyst insights and predictive analysis of the market.
Market Segmentation
1. Global Pernicious Anemia Market by Diagnosis
• Complete Blood Count Test
• Vitamin B-12 Deficiency Test
• Biopsy
2. Global Pernicious Anemia Market by Treatment
• Vitamin B-12 Injections
• Vitamin B-12 Pills
3. Global Pernicious Anemia Market by End-User
• Hospitals
• Diagnostic Centers and Clinics
• Homecare
Region Covered
• North America (the US and Canada)
• Europe (United Kingdom, Germany, France, Spain, and Italy)
• Asia-Pacific (China, India, South Korea, and Japan)
• Rest of the Word (the Middle East & Africa and Latin America)
Company Profiled
• Alfasigma USA, Inc.
• AMAG Pharmaceuticals, Inc.
• American Regent, Inc.
• BBI Group Holding Ltd.
• Bio-Rad Laboratories, Inc.
• BioVision, Inc.
• Cleveland HeartLab, Inc.
• Daiichi Sankyo Co., Ltd.
• Emisphere Technologies, Inc.
• Endo Pharmaceuticals, Inc.
• GlaxoSmithKline, PLC
• Koninklijke DSM N.V.
• Laboratory Corporation of America Holdings
• Medline Industries, Inc.
• Merck KGaA
• Monobind, Inc.
• Pfizer, Inc.
• Pharmacosmos A/S
• Pharmavite, LLC
• Premier Research Labs
• Swanson Health Products
• Takeda Pharmaceutical Co., Ltd.
• The Synergy Co.
• Trinity Biotech PLC
For related reports please visit https://www.omrglobal.com/reports-category/healthcare/
For more update follow LinkedIn https://www.linkedin.com/company/omr-global-research/
About Orion Market Research
Orion Market Research (OMR) a research company known for its crisp and concise reports. The company is equipped with an experienced team and young brigade of analysts. The company aims to provide business insights for decision making to the global clients and offers quality syndicated research reports, customized research reports, Company profiling, consulting and other research-based services. OMR provide global and regional market reports of various domains such as healthcare, energy, IT, chemicals, and automobiles. OMR provide a 360-degree view of the market with parametric analysis, key market insights, key findings, statistical forecasts, competitive landscape, extensive segmentation, key trends, strategic recommendations and detailed company profiles.
Contact us
Orion Market Research Pvt. Ltd.
Anurag Tiwari
Email: info@omrglobal.com
India: +91 7803040404
Global:+1 6467557667
Indore-India-452010
Web: www.omrglobal.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Pernicious Anemia Market Research and Forecast, 2018-2023 here
News-ID: 1638111 • Views: …
More Releases from Orion Market Research
AI-Enabled Imaging Modalities Market Rising Demand and Growth Forecast Through 2 …
AI-enabled imaging modalities market was valued at approximately USD 1.36 billion, and it is projected to reach around USD 19.78 billion by 2033, reflecting a compound annual growth rate (CAGR) of about 34.67% from 2024 to 2033.
AI-Enabled Imaging Modalities Market Overview
The AI-enabled imaging modalities market is experiencing rapid growth, driven by advancements in artificial intelligence and machine learning technologies. These innovations are enhancing the capabilities of various imaging modalities, including…
Tumor Tracking Systems Market Size Analysis, Competitive Insights, Leading Playe …
Global tumor tracking systems market was valued at approximately USD 3.5 billion, and it is projected to reach around USD 6.6 billion by 2033, reflecting a compound annual growth rate (CAGR) of about 5% from 2024 to 2033.
Tumor Tracking Systems Market Overview
The tumor tracking systems market is experiencing steady growth, driven by the increasing incidence of cancer and advancements in imaging and tracking technologies. These systems improve the precision of…
Tumor Tracking Systems Market Size Future Scope, Demands and Projected Industry …
Tumor tracking systems market was valued at approximately USD 3.5 billion, and it is projected to reach around USD 6.6 billion by 2033, reflecting a compound annual growth rate (CAGR) of about 5% from 2024 to 2033.
Tumor Tracking Systems Market Overview
The tumor tracking systems market is experiencing steady growth, driven by the increasing prevalence of cancer and advancements in imaging technologies. These systems play a crucial role in enhancing the…
SNP genotyping Market Size Analysis, Competitive Insights, Leading Players and G …
SNP genotyping market was valued at approximately USD 31.66 billion, and it is projected to reach around USD 238.25 billion by 2034, reflecting a compound annual growth rate (CAGR) of about 20.1% from 2024 to 2034.
SNP genotyping Market Overview
The SNP genotyping market is experiencing significant growth, driven by advancements in genotyping technologies, an increase in the prevalence of genetic disorders, and the expansion of pharmacogenomics and precision medicine initiatives. This…
More Releases for Pernicious
Pernicious Anemia Diagnosis And Treatment Market Forecast 2025-2034: Comprehensi …
"Our market reports now include the latest updates on global tariffs, trade impacts, and evolving supply chain dynamics.
What Is the Projected Growth of the Pernicious Anemia Diagnosis And Treatment Market?
In recent years, the market size for diagnosing and treating pernicious anemia has seen robust growth. It is projected to expand from $1.42 billion in 2024 to $1.52 billion in 2025, presenting a compound annual growth rate (CAGR) of 7.0%. The…
Cyanocobalamin Injection Market Analysis, Key Trends, Growth Opportunities, Chal …
The most recent Cyanocobalamin Injection Market statistical surveying report involves a complete evaluation of Cyanocobalamin Injection industry, featuring the variables that will affect the business' income stream during the assessed course of events. Further, it gives an expressive framework of the open possibilities in the sub-promotes close by measures to profit from something almost identical.
Cyanocobalamin injection is a type of vitamin B12 injection used to treat a number of illnesses,…
Pernicious Anemia Testing Market is Grabbing New opportunities by International …
Overview of Global Pernicious Anemia Testing Market:
Actionable insights and market data provided in the persuasive Pernicious Anemia Testing Market report aids in strategizing business growth by an astute and authoritative DBMR team. The document focuses on smaller, singular subjects, issues, or populations, rather than an overall market sample. This industry analysis document illuminates more accurate details about the exact business. The marketing report has considerate information about the business's buyer…
Global Pernicious Anemia Diagnosis and Treatment Market Size, Growth Analysis Re …
The global pernicious anemia diagnosis and treatment market is anticipated to grow at a considerable CAGR of 7.1% during the forecast period (2021-2027). However, the COVID-19 had sidelined the diagnosis and treatment of other major as well as minor diseases. Pernicious anemia is one of them which are caused by the deficiency of vitamin B12. Diabetic elders are most likely to have this disease, however, youngsters are also found to…
Pernicious Anemia Testing Market 2020: Industry Analysis and Forecast : Top Key …
The Global Pernicious Anemia Testing Market study with 100+ market data Tables, Pie Chat, Graphs & Figures is now released by Data Bridge Market Research. This Global Pernicious Anemia Testing Market report provides explanation about the detailed market analysis with inputs from industry experts. Competitive landscape in this report covers strategic profiling of key players in the market, comprehensively analyzing their core competencies, and strategies. The data and information regarding the industry are taken…
The Parietal Cell Antibodies market to grow on a prudent note from 2019 to 2029
Parietal cell antibodies refer to the autoantibodies, which are produced by the immune system and mistakenly target the specialized cell of the stomach. The parietal cell antibodies test is used to diagnose pernicious anemia. Pernicious anemia is an autoimmune condition, in which immune system targets its own tissues and plays an important role in the development of antibodies. The common symptoms observed in the case of pernicious anemia includes pale…
